Literature DB >> 10378602

Secondary coloperineal pull-through and double dynamic graciloplasty after Miles resection--feasible, but with a high morbidity.

M J Rongen1, F A Dekker, B P Geerdes, E Heineman, C G Baeten.   

Abstract

PURPOSE: Until recently, patients who underwent abdominoperineal resections had to cope with a colostomy for the rest of their lives. For some of these patients this colostomy was a terrible burden, physically and mentally. Publications about abdominoperineal pull-through and double dynamic graciloplasty immediately after a Miles resection showed good results. The purpose of this study was to investigate the procedure as a secondary approach after abdominoperineal resections.
METHODS: In this study seven patients were evaluated. All had had an abdominoperineal resection and proved to have unbearable problems with their stoma. All had a secondary pull-through and double dynamic graciloplasty, a mean of 8.5 (range, 1.1-34.8) years after the Miles resection.
RESULTS: In five patients continence was regained; two were reversed to colostomy because of several complications. Patients who had a successful outcome also suffered from numerous complications, with a total mean hospital stay of 73.8 (range, 27-167) days, a mean of 3.1 (range, 1-6) additional operations, and 1.8 (range, 0-4) readmissions.
CONCLUSION: Secondary anorectal reconstruction after abdominoperineal resection is a feasible option, but with a high morbidity. Because of this the procedure was stopped at the beginning of 1997.

Entities:  

Mesh:

Year:  1999        PMID: 10378602     DOI: 10.1007/bf02236934

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  2 in total

1.  [Anal sphincter replacement].

Authors:  C G M I Baeten
Journal:  Chirurg       Date:  2004-01       Impact factor: 0.955

2.  Dynamic graciloplasty for total anorectal reconstruction after abdominoperineal resection for rectal tumour.

Authors:  K S Ho; F Seow-Choen
Journal:  Int J Colorectal Dis       Date:  2004-08-04       Impact factor: 2.571

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.